Jeffrey A. Meckler, CEO and Director at Indaptus Therapeutics, Inc. (INDP), bought 39,454 shares at $2.63 ($104K) on 2022-06-06, disclosed to the SEC on 2022-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.63 | 19,727 | $52K | 50.0% |
| 2 | $2.63 | 19,727 | $52K | 50.0% |
| Total | $2.63 avg | 39,454 | $104K | 100% |
| Filing → |
| TVTX | SELL | 2024-09-30 | $562K | — | Filing → |
| INDP | BUY | 2022-11-22 | $19K | — | Filing → |
| INDP | BUY | 2022-09-12 | $29K | — | Filing → |